A. Meima, L. M. Irgens, G. J. Van-oortmarssen, J. H. Richardus, and J. D. Habbema, Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach, International Journal of Epidemiology, vol.31, issue.5, pp.31-991, 2002.
DOI : 10.1093/ije/31.5.991

D. S. Ridley and W. H. Jopling, Classification of leprosy according to immunity . A five-group system, Int. J. Lepr. Other Mycobact. Dis, p.34, 1966.

W. J. Britton and D. N. Lockwood, Leprosy, The Lancet, vol.363, issue.9416, pp.1209-1219, 2004.
DOI : 10.1016/S0140-6736(04)15952-7

R. R. Jacobson and J. L. , Leprosy, The Lancet, vol.353, issue.9153, pp.655-660, 1999.
DOI : 10.1016/S0140-6736(98)06322-3

. Anon, Report of the International Leprosy Association Technical Forum, Int. J. Lepr. Other Mycobact. Dis, vol.70, p.supp), 2002.

S. Buhrer-sekula, M. G. Cunha, N. T. Foss, L. Oskam, W. R. Faber et al., Dipstick assay to identify leprosy patients who have an increased risk of relapse, Tropical Medicine and International Health, vol.63, issue.4, pp.317-323, 2001.
DOI : 10.1016/S0928-8244(98)00049-2

S. Buhrer-sekula, H. L. Smits, and G. C. Gussenhoven, Simple and Fast Lateral Flow Test for Classification of Leprosy Patients and Identification of Contacts with High Risk of Developing Leprosy, Journal of Clinical Microbiology, vol.41, issue.5, p.41, 2003.
DOI : 10.1128/JCM.41.5.1991-1995.2003

S. N. Cho, R. V. Cellona, and L. G. Villahermosa, Detection of Phenolic Glycolipid I of Mycobacterium leprae in Sera from Leprosy Patients before and after Start of Multidrug Therapy, Clinical and Vaccine Immunology, vol.8, issue.1, pp.138-142, 2001.
DOI : 10.1128/CDLI.8.1.138-142.2001

S. N. Cho, S. H. Kim, and R. V. Cellona, Prevalence of IgM antibodies to phenolic glycolipid I among household contacts and controls in Korea and the Philippines, Lepr. Rev, pp.63-75, 1992.

S. T. Cole, K. Eiglmeier, and J. Parkhill, Massive gene decay in the leprosy bacillus, Nature, vol.409, issue.6823, 2001.
DOI : 10.1038/35059006

P. Brodin, I. Rosenkrands, P. Andersen, S. T. Cole, and R. Brosch, ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol, pp.12-500, 2004.

A. L. Sorensen, S. Nagai, G. Houen, P. Andersen, and A. B. Andersen, Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis, Infect. Immun, pp.63-1710, 1995.

J. S. Rothel and P. Andersen, Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?, Expert Rev. Anti Infect. Ther, vol.3, 2005.

K. Ewer, J. Deeks, and L. Alvarez, Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak, The Lancet, vol.361, issue.9364, pp.1168-1173, 2003.
DOI : 10.1016/S0140-6736(03)12950-9

R. Araoz, N. Honoré, and S. Cho, Antigen Discovery: a Postgenomic Approach to Leprosy Diagnosis, Infection and Immunity, vol.74, issue.1, pp.74-175, 2006.
DOI : 10.1128/IAI.74.1.175-182.2006

URL : https://hal.archives-ouvertes.fr/pasteur-00204119

H. M. Dockrell, S. Brahmbhatt, and B. D. Robertson, A Postgenomic Approach to Identification of Mycobacterium leprae-Specific Peptides as T-Cell Reagents, Infection and Immunity, vol.68, issue.10, pp.68-5846, 2000.
DOI : 10.1128/IAI.68.10.5846-5855.2000

A. Geluk, M. R. Klein, and K. L. Franken, Postgenomic Approach To Identify Novel Mycobacterium leprae Antigens with Potential To Improve Immunodiagnosis of Infection, Infection and Immunity, vol.73, issue.9, pp.73-5636, 2005.
DOI : 10.1128/IAI.73.9.5636-5644.2005

J. S. Spencer, H. M. Dockrell, and H. J. Kim, Identification of Specific Proteins and Peptides in Mycobacterium leprae Suitable for the Selective Diagnosis of Leprosy, The Journal of Immunology, vol.175, issue.12, pp.175-7930, 2005.
DOI : 10.4049/jimmunol.175.12.7930

J. S. Spencer, H. J. Kim, and A. M. Marques, Comparative analysis of Band T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10, Infect. Immun, pp.72-3161, 2004.

R. Hussain, A. Kaleem, and F. Shahid, Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population, Journal of Immunological Methods, vol.264, issue.1-2, pp.95-108, 2002.
DOI : 10.1016/S0022-1759(02)00092-3

C. Demangel, P. Brodin, and P. J. Cockle, Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of CFP-10 and ESAT-6, Infect. Immun, pp.72-2170, 2004.

C. Demangel, T. Garnier, I. Rosenkrands, and S. T. Cole, Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination with Mycobacterium bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens, Infection and Immunity, vol.73, issue.4, pp.73-2190, 2005.
DOI : 10.1128/IAI.73.4.2190-2196.2005

H. Singh and G. P. Raghava, ProPred: prediction of HLA-DR binding sites, Bioinformatics, vol.17, issue.12, 2001.
DOI : 10.1093/bioinformatics/17.12.1236

N. Desem and S. L. Jones, Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection, Clin. Diagn. Lab. Immunol, vol.5, pp.531-536, 1998.

P. Ravn, M. E. Munk, and A. B. Andersen, Prospective Evaluation of a Whole-Blood Test Using Mycobacterium tuberculosis-Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active Tuberculosis, Clinical and Vaccine Immunology, vol.12, issue.4, pp.491-496, 2005.
DOI : 10.1128/CDLI.12.4.491-496.2005

M. E. Amezcua, A. Escobar-gutierrez, and J. Barba-rubio, Prospective immunological follow-up in household contacts of Mexican leprosy patients, Int. J. Lepr. Other Mycobact. Dis, pp.58-651, 1990.

M. Ulrich, P. G. Smith, and . Sampson, IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy, Int. J. Lepr. Other Mycobact. Dis, pp.59-405, 1991.

H. N. Lee, C. S. Embi, K. M. Vigeland, and C. R. White, Concomitant pulmonary tuberculosis and leprosy, Journal of the American Academy of Dermatology, vol.49, issue.4, pp.49-755, 2003.
DOI : 10.1067/S0190-9622(03)00456-0

P. E. Fine, J. A. Sterne, J. M. Ponnighaus, and R. J. Rees, Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity, The Lancet, vol.344, issue.8932, pp.1245-1249, 1994.
DOI : 10.1016/S0140-6736(94)90748-X

A. Geluk, K. E. Van-meijgaarden, and K. L. Franken, Immunological cross reactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis, Scand. J. Immunol, vol.66, issue.70, p.59, 2004.

A. Geluk, K. E. Van-meijgaarden, and K. L. Franken, Identification and Characterization of the ESAT-6 Homologue of Mycobacterium leprae and T-Cell Cross-Reactivity with Mycobacterium tuberculosis, Infection and Immunity, vol.70, issue.5, pp.70-2544, 2002.
DOI : 10.1128/IAI.70.5.2544-2548.2002